Azenta, Inc. (AZTA)

Sample management products and genomics services. Read November 9, 2026 from the annual report for the period ending September 30, 2025, filed December 4, 2025. Ranked 44 of the 145 Healthcare companies read so far, by the share within reach now.

The filing states approximately 3,000 employees and contingent workers at September 30, 2025, primarily in the United States, with services 71% of revenue, so the repository and genomics services lead at scientific R&D services and the automated stores and consumables take medical equipment manufacturing by description.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 35% now, 50% at the end of 2027, 56% at the end of 2028, 58% at the end of 2030. By the patterns, the work is about 58% desk work, 17% people work and 25% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 41% of the working time stays with people (conversation, in-person and hands-on work), 51% becomes checking a model's work and 6% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

3,000 employees as of September 30, 2025 (stated). Stated in words only: primarily in the United States.

The filing: “In total, we employ approximately 3,000 full-time employees, part-time employees and contingent workers worldwide as of September 30, 2025, primarily in the United States.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 3,000 full-time employees, part-time employees and contingent workers worldwide at September 30, 2025, primarily in the United States, down from 3,300 a year earlier; about 48% gender diverse and 43% of U.S. employees racially diverse; sales in about 95 countries.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Scientific Research and Development Services, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.

• IQVIA Holdings Inc. (IQV, 93,000 employees)43% now, 67% by 2028
• Charles River Laboratories International, Inc. (CRL, 19,700 employees)37% now, 61% by 2028
• Fortrea Holdings Inc. (FTRE, 14,300 employees)38% now, 64% by 2028
• Medpace Holdings, Inc. (MEDP, 6,200 employees)38% now, 64% by 2028

What the filing says about AI

11 sentences in the filing name AI. The filing carries a risk section on artificial intelligence: ineffective development or deployment of AI could lead to errors, biases or disruptions in its operations, evolving AI regulation could impose compliance burdens, and AI is transforming life sciences through faster data analysis, personalized medicine and genomic services.

• “Risks Related to Artificial Intelligence ● Ineffective development or deployment of AI technologies could lead to errors, biases, or disruptions in our operations. ● Evolving AI regulations could impose compliance burdens and limit our use of AI.”
• “These information systems include telecommunications, the internet, our corporate intranet, various computer hardware and software applications (including AI-enabled tools), network communications and e-mail.”
• “Risks Related to Artificial Intelligence The development, adoption, and use of artificial intelligence ("AI") technologies are rapidly transforming the life sciences industry, enabling faster data analysis, personalized medicine, and advancements in genomic services and sample management through machine learning and predictive modeling.”
• “However, AI presents risks and challenges that could adversely impact our business.”
• “As with many innovations, ineffective or inadequate AI development or deployment practices could result in unintended consequences.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20230median 1
• Fiscal 20240median 4
• Fiscal 202511median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The stated 3,000 includes contingent workers the filing does not count apart, so it is recorded as stated and flagged (rule 8).
• The U.S. share is given in words (primarily in the United States) and left null.
• The split between services and products follows the revenue lines (c); the filing counts nothing by segment.

Source: the company's annual report on EDGAR, accession 0001437749-25-036931, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.